Gideon Agbomanyi

Performed LC/MS-based in vitro ADME assays and generated pharmacokinetic data to characterize lead antimalarial compounds, informing medicinal chemistry optimization and translational decisions with MMV and H3D collaborators.

Assisted molecular docking and in vitro/in vivo antiplasmodial assays for pyrazole derivatives, contributing to IC50 determinations, toxicity assessments, and bioanalysis to support lead evaluation.

Conducted literature reviews and zebrafish husbandry to develop protocols for assaying cardio-, hepato-, reno-, neuro- and developmental toxicities from heavy metal–contaminated water and bioaccumulated metals.

Participated in ward rounds to optimize medication regimens, counseled discharged patients to support adherence, and collaborated with clinical teams to ensure safe pharmacotherapy.

Gained hands-on experience in pharmaceutical production and quality control, observing HPLC/UV analyses and learning formulation, stability testing, and regulatory submission processes.

Verified medication orders, prepared extemporaneous formulations, ensured inventory compliance, and monitored for drug interactions to promote customer safety.

Assisted pharmacists with medication preparation and distribution, provided patient counseling on drug interactions and side effects, and compounded medications per prescriptions.

Activities and societies: Thesis research on zebrafish cardiotoxicity; academic research elective; multiple research assistant roles related to ADME, antimalarial drug discovery, and toxicity assessment.

Doctor of Pharmacy (PharmD) program with a thesis on acute herbal drug-induced cardiotoxicity testing using zebrafish as a model.